Effects of Fostamatinib, an Oral Spleen Tyrosine Kinase Inhibitor, in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate: Results From a Phase III, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Study

Publisher: John Wiley & Sons Inc

E-ISSN: 2326-5205|66|12|3255-3264

ISSN: 2326-5191

Source: ARTHRITIS & RHEUMATOLOGY, Vol.66, Iss.12, 2014-12, pp. : 3255-3264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content